-The Indian Express Government privileges the private over the public, preferring trade to health In a dramatic development, US industry groups recently claimed the Indian government offered them a “private” assurance that compulsory licences will not be issued, save in emergencies and for non-commercial purposes. Needless to state, such an assurance flies in the face of the Patents Act and the public health safeguards enshrined in it. Illustratively, Section 84 mandates that...

-The Hindu The Aadhaar (Targeted Delivery of Financial and Other Subsidies, Benefits and Services) Bill, 2016, better known as Aadhaar Bill, was introduced in Lok Sabha on March 3. The Bill intends to provide for targeted delivery of subsidies and services to individuals residing in India by assigning them unique identity numbers. Parliament is debating on the certain portions of the Bill, which may need clarification or amendments: 1. Allowing private agencies to use...

-The Hindu If the Indian government is serious about its commitment to realise the rights of its citizens to universal and equitable health care, it cannot ignore rare diseases. The draft National Health Policy, 2015, makes no mention of them Rare diseases are a diverse set of over 7,000 different conditions that afflict an estimated 1 in 20 Indians and 350 million people worldwide. Put simply, it means that every bus on...

-The Indian Express Never before has India’s agricultural science community been as demoralised as now Everyone knows Indian agriculture is in deep crisis, impacting around 115 million farmers and an equal number of landless cultivators. Two consecutive bad monsoons and falling commodity prices have resulted in the imports of edible oils and pulses touching all-time-highs, even as its exports of agri-products — from basmati rice, soya meal, sugar, milk powder and...

-The Hindu Medicines remain overpriced and unaffordable in India. In a country mired in poverty, medical debt remains the second biggest factor for keeping millions in poverty. The international pharmaceutical industry has found its cash cow in India’s beleaguered consumers. With a minimum wage of Rs.250/day for a government worker, a basic wage worker afflicted with a chronic disease like multi-drug-resistant tuberculosis faces penury. His treatment, with drug combinations, which works out...